• Sir Ronald Cohen: ‘Transparency is going to disrupt companies delivering negative impacts’

    INTERVIEW: Putting a price tag on a company’s social and environmental impact is the only way to demonstrate its true profit and loss, believes Sir Ronald Cohen, who is now focusing on driving forward the next accounting revolution.

  • Investor in Focus: NESsT

    INTERVIEW: Founded in 1990s eastern Europe, NESsT is still helping high-impact organisations to grow, and not rely on grants. We hear how it makes extra efforts to track its own impact – and how a new fund is tackling LGBTQIA+ discrimination.

  • VC investment for impact pulls back in 2022 worldwide – new research

    Following record investments in 2021, deals are lower this year, Dealroom’s Impact Database reveals this week. Yet impact startups remain collectively valued at more than US$2tn and “impact unicorns” have reached 200.

  • 'The more companies we work with, the more risk there is' - B Lab's Dan Osusky

    INTERVIEW: As B Lab leads a "substantial revisit" of the criteria for companies seeking B Corp status, we ask the man who oversees these standards what will change – and if recent criticism of B Corp certifications is justified.

  • True and Fair? How directors should be presenting accounts in the 21st century

    Company directors’ reliance on international accounting standards means sustainability issues are currently reported separately, if at all. But there are steps they can take to better meet their legal responsibilities, says our columnist.

The Impact World This Week: 20 February 2025

This week: Syria’s first hackathon unites social innovators to support recovery; UK government backs social enterprise in public procurement rules shake-up; Alfanar’s MENA impact fund launch is “good news for impact investing”.

The Impact World This Week: 13 February 2025

This week: impact investors unite against US foreign aid freeze; sustainability gets lukewarm embrace at Paris AI summit; concerns raised about UK government’s social investment advisory group members; and more.